Ovid Therapeutics (1OT.MU) Q2 2026 Earnings

13MayConfirmed
Q1 2026
Next
-0.11
-0.05
-0
0.05

Details

Expected EPS
-0.10552559459000001
Actual EPS
N/A
Surprise EPS
0.11
Surprise Percent
+100%

Description

Ovid Therapeutics (1OT.MU) will report earnings of for Q2 2026 on May 13, 2026.

0 Comments

Share your thoughts